Pamidronate Disod 90 Mg VialInjection
Sandoz Private Ltd. Generic : Pamidronate
₹ 755.64 90mg 1vial
Adult: IV- Paget's disease of bone- 30 mg/day for 3 consecutive days.
Hypercalcemia- 60 to 90mg, as single dose, over 2 to 24 hours.
Multiple Myeloma with bone disease- 90 mg administered as a 4-hour infusion given on a monthly basis.
Generalized pain, fever, reactivation of viral diseases. Flu-like reaction may occur initially.
Heart : High blood pressure, abnormal heart rate or rhythm, heart failure, syncope.
Central Nervous System: Confusion, visual hallucinations, electrolyte imbalance, sleeplessness, nervousness, drowsiness, mental or mood changes.
Gastrointestinal: Abdominal pain, loss of appetite, constipation, nausea, vomiting, diarrhea, mouth ulcer, gastrointestinal hemorrhage, osteonecrosis of jaw.
Genitourinary: Increased blood urea, renal tubular disorders (RTD).
Skin : Rash, itching.
Eye: Inflammation of eye tissues.
Blood: Decrease in red blood cells, white blood cells and platelets.
Metabolic: Low thyroid hormone, decrease in calcium, potassium, magnesium, phosphate level in blood.
♦Respiratory: Runny nose, upper respiratory infection, adult respiratory distress syndrome (ARDS and interstitial lung disease (ILD).
Musculoskeletal: Bone and muscle pain
Rare instances of allergic manifestations have been reported, including low blood pressure, difficulty in breathing, or angioedema, and, very rarely, anaphylactic shock.
Potentially Fatal: Acute kidney and heart failure.
It comes as a solution to inject into a vein, administered by a healthcare provider.
Contraindicated to pregnant women and patients with known hypersensitivity.
Patient may develop bone, muscle pain at anytime after starting this medication.
Injection: Store it at room temperature. After reconstitution: Stable for up to one day when refrigerated at 2-8°C.♦ Safety Labeling Changes Approved By FDA